{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:40:05Z","timestamp":1718826005582},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0368-2","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T13:13:51Z","timestamp":1475586831000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Damian J.","family":"Damian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roseanne","family":"McNamee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"key":"368_CR1","first-page":"127","volume-title":"Hypertension - Clinical management of primary hypertension in adults. NICE clinical guideline","author":"National Institute for Health and Care Excellence","year":"2011","unstructured":"National Institute for Health and Care Excellence. Hypertension - Clinical management of primary hypertension in adults. NICE clinical guideline. 2011. p. 127."},{"key":"368_CR2","unstructured":"World Health Organization. Global health risks: Mortality and burden of disease attributable to selected major risks. Bull World Health Organ. 2009;87:646\u20136."},{"key":"368_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0140-6736(10)62036-3","volume":"377","author":"G Danaei","year":"2011","unstructured":"Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM, Ezzati M. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5\u00b74 million participants. Lancet. 2011;377:568\u201377.","journal-title":"Lancet"},{"key":"368_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0735-1097(01)01728-4","volume":"39","author":"L Opie","year":"2002","unstructured":"Opie L, Schal R. Evidence-based evaluation of calcium channel blockers for hypertension equality of mortality and cardiovascular risk relative to conventional therapy. J Am Coll Cardiol. 2002;39:315\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"368_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC, Svetkey LP, Taler SJ, Townsend RR, Wright JT, Navra AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507\u201320.","journal-title":"JAMA"},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/jch.12445","volume":"16","author":"KA Redburn","year":"2014","unstructured":"Redburn KA, Niebylski ML. Excellence and notable achievement awards from the world hypertension league: a call for 2015 nominations. J Clin Hypertens. 2014;16:927\u20139.","journal-title":"J Clin Hypertens"},{"key":"368_CR7","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","volume":"126","author":"Q Gu","year":"2012","unstructured":"Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among united states adults with hypertension: the national health and nutrition examination survey, 2001 to 2010. Circulation. 2012;126:2105\u201314.","journal-title":"Circulation"},{"key":"368_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/jch.12413","volume":"16","author":"L Wilson","year":"2014","unstructured":"Wilson L, Nair KV, Saseen JJ. Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension. J Clin Hypertens (Greenwich). 2014;16:864\u20138.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"368_CR9","volume-title":"Veteran adminstration\/department of defence practise guidelines for diagnosis and management of hypertension in the primary care setting","author":"Department of Veterans Administration","year":"2004","unstructured":"Department of Veterans Administration. Veteran adminstration\/department of defence practise guidelines for diagnosis and management of hypertension in the primary care setting. Washington D.C: Veteran Adminstration and Department of Defence; 2004."},{"key":"368_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/01.HYP.19.4.393","volume":"19","author":"BR Davis","year":"1992","unstructured":"Davis BR, Davis BR, Oberman A, Blaufox MD, Wassertheil-Smoller S, Hawkins CM, Cutler JA, Zimbaldi N, Langford HG. Effect of antihypertensive therapy on weight loss. The trial of antihypertensive interventions and management research group. Hypertension. 1992;19:393\u20139.","journal-title":"Hypertension"},{"key":"368_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/01.HYP.12.3.244","volume":"12","author":"ED Freis","year":"1988","unstructured":"Freis ED, Reda DJ, Materson BJ. Volume (weight) loss and blood pressure response following thiazide diuretics. Hypertension. 1988;12:244\u201350.","journal-title":"Hypertension"},{"key":"368_CR12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/NEJM198909283211305","volume":"321","author":"T Pollare","year":"1989","unstructured":"Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321:868\u201373.","journal-title":"N Engl J Med"},{"key":"368_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1524-6175.2006.05139.x","volume":"8","author":"SA Sica","year":"2006","unstructured":"Sica SA. Antihypertensive therapy and its effects on potassium homeostasis. J Clin Hypertens. 2006;8:67\u201373.","journal-title":"J Clin Hypertens"},{"key":"368_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/BF02014933","volume":"3","author":"Y Doi","year":"1994","unstructured":"Doi Y, Aoi W, Suzuki S, Seto S, Baba K, Yano K. Changes in total body potassium during long-term thiazide treatment: Effects of potassium supplements on total body and serum potassium in hypertensive patients with thiazide treatment. Int J Angiol. 1994;3:142\u20137.","journal-title":"Int J Angiol"},{"key":"368_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1177\/000331977602701205","volume":"27","author":"SG Chrysant","year":"1976","unstructured":"Chrysant SG, Neller GK, Dillard B, Frohlich ED. Effects of diuretics on lipid metabolism in patients with essential hypertension. Angiology. 1976;27:707\u201311.","journal-title":"Angiology"},{"key":"368_CR16","doi-asserted-by":"crossref","unstructured":"Andreucci VE, Del Canton A (eds.). Diuretics: Basic, Pharmacological, and Clinical Aspects: Proceedings of the International Meeting on Diuretics, Sorrento, Italy, May 26\u201330, 1986. Naples: Springer Science & Business Media; 2012.","DOI":"10.1007\/978-1-4613-2067-8"},{"key":"368_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5049\/EBP.2010.8.1.51","volume":"8","author":"KS Hwang","year":"2010","unstructured":"Hwang KS, Kim G-H. Thiazide-induced hyponatremia. Electrolyte Blood Press. 2010;8:51\u20137.","journal-title":"Electrolyte Blood Press"},{"key":"368_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/art.38203","volume":"66","author":"S Bruderer","year":"2014","unstructured":"Bruderer S, Bodmer M, Jick SS, Meier CR. Use of diuretics and risk of incident gout: a population-based case-control study. Arthritis Rheumatol (Hoboken, NJ). 2014;66:185\u201396.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"368_CR19","first-page":"27","volume":"1","author":"MR Wofford","year":"1999","unstructured":"Wofford MR, Andrew ME, Brown A, King D, Pickett RA, Stevens J, Wyatt S, Jones DW. Obesity hypertension in the atherosclerosis risk in communities cohort: implications of obesity guidelines. J Clin Hypertens (Greenwich). 1999;1:27\u201332.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"368_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2165\/00129784-200606030-00001","volume":"6","author":"TA Aksnes","year":"2006","unstructured":"Aksnes TA, Kjeldsen SE, Mancia G. The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines? Am J Cardiovasc Drugs. 2006;6:139\u201347.","journal-title":"Am J Cardiovasc Drugs"},{"key":"368_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/00004872-200308000-00022","volume":"21","author":"L Lindholm","year":"2003","unstructured":"Lindholm L, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O. Metabolic outcome during 1\u00a0year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J Hypertens. 2003;21:1563\u201374.","journal-title":"J Hypertens"},{"issue":"Suppl G","key":"368_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/eurheartj\/13.suppl_G.68","volume":"13","author":"LE Ramsay","year":"1992","unstructured":"Ramsay LE, Yeo WW, Jackson PR. Diabetes, impaired glucose tolerance and insulin resistance with diuretics. Eur Heart J. 1992;13(Suppl G):68\u201371.","journal-title":"Eur Heart J"},{"key":"368_CR23","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1097\/01.hjh.0000249686.65994.97","volume":"24","author":"LH Lindholm","year":"2006","unstructured":"Lindholm LH, Carlberg B, Samuelsson O. Beta blockers in primary hypertension: Do age and type of beta-blocker matter? J Hypertens. 2006;24:2143\u20135.","journal-title":"J Hypertens"},{"key":"368_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","volume":"304","author":"MRC Working Party","year":"1992","unstructured":"MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ. 1992;304:405\u201312.","journal-title":"BMJ"},{"key":"368_CR25","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1503\/cmaj.060110","volume":"174","author":"N Khan","year":"2006","unstructured":"Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ. 2006;174:1737\u201342.","journal-title":"CMAJ"},{"key":"368_CR26","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/HJH.0b013e3283568a73","volume":"30","author":"MJ Carr","year":"2012","unstructured":"Carr MJ, Bao Y, Pan J, Cruickshank K, McNamee R. The predictive ability of blood pressure in elderly trial patients. J Hypertens. 2012;30:1725\u201333.","journal-title":"J Hypertens"},{"key":"368_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3109\/10641969309037083","volume":"15","author":"AF Lever","year":"1993","unstructured":"Lever AF, Brennan PJ. MRC trial of treatment in elderly hypertensives. Clin Exp Hypertens. 1993;15:941\u201352.","journal-title":"Clin Exp Hypertens"},{"key":"368_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0140-6736(96)07099-7","volume":"349","author":"G Mancia","year":"1997","unstructured":"Mancia G, Sega R, Milesi C, Cessna G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet. 1997;349:454\u20137.","journal-title":"Lancet"},{"key":"368_CR29","volume-title":"17th expert committee on the selection and use of essential medicines","author":"Street Edith","year":"2009","unstructured":"Street Edith. 17th expert committee on the selection and use of essential medicines. Geneva: World Health Organization; 2009."},{"key":"368_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/08037050601164986","volume":"15","author":"K Narkiewicz","year":"2006","unstructured":"Narkiewicz K, Kjeldsen SE, Oparil S, Hedner T. Beta-blockers as sub-optimal treatment for hypertension: time for first-line therapy revision? Blood Press. 2006;15:323\u20134.","journal-title":"Blood Press"},{"key":"368_CR31","unstructured":"Meiner S. Gerontologic Nursing. Maryland Heights: Elsevier Mosby. 2014."},{"key":"368_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/01.HYP.37.2.250","volume":"37","author":"AM Sharma","year":"2001","unstructured":"Sharma AM, Pischon T, Hardt S, Kunz I, Luft FC. Hypothesis: -adrenergic receptor blockers and weight gain : a systematic analysis. Hypertension. 2001;37:250\u20134.","journal-title":"Hypertension"},{"key":"368_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF01883857","volume":"3","author":"L Poulsen","year":"1989","unstructured":"Poulsen L, Friberg M, Noer I, Krusell L, Pedersen OL. Comparison of indapamide and hydrochlorothiazide plus amiloride as a third drug in the treatment of arterial hypertension. Cardiovasc Drugs Ther. 1989;3:141\u20134.","journal-title":"Cardiovasc Drugs Ther"},{"key":"368_CR34","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/jcem-57-5-920","volume":"57","author":"D Leppla","year":"1983","unstructured":"Leppla D, Browne R, Hill K, Pak CYC. Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts. J Clin Endocrinol Metab. 1983;57:920\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"368_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/bmj.280.6218.905","volume":"280","author":"DB Morgan","year":"1980","unstructured":"Morgan DB, Davidson C. Hypokalaemia and diuretics: an analysis of publications. Br Med J. 1980;280:905\u20138.","journal-title":"Br Med J"},{"key":"368_CR36","unstructured":"Messerli FH (ed.). Kidney in Essential Hypertension: Proceedings of the Course on the Kidney in Essential Hypertension held at New Orleans, Louisiana, March 18\u201319, 1983. Springer Science & Business Media. 2012."},{"key":"368_CR37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/archinte.159.6.551","volume":"159","author":"MR Lakshman","year":"1999","unstructured":"Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med. 1999;159:551\u20138.","journal-title":"Arch Intern Med"},{"key":"368_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7326\/0003-4819-122-2-199501150-00010","volume":"122","author":"BL Kasiske","year":"1995","unstructured":"Kasiske BL, Ma JZ, Kalil RS, Louis TA. Effects of antihypertensive therapy on serum lipids. Ann Intern Med. 1995;122:133\u201341.","journal-title":"Ann Intern Med"},{"key":"368_CR39","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/archinte.158.7.741","volume":"158","author":"PJ Savage","year":"1998","unstructured":"Savage PJ. Influence of Long-term, Low-Dose, Diuretic-Based, Antihypertensive Therapy on Glucose, Lipid, Uric Acid, and Potassium Levels in Older Men and Women With Isolated Systolic HypertensionThe Systolic Hypertension in the Elderly Program. Arch Intern Med. 1998;158:741.","journal-title":"Arch Intern Med"},{"key":"368_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.0954-6820.1979.tb00781.x","volume":"628","author":"C Bengtsson","year":"1979","unstructured":"Bengtsson C. Elevated serum uric acid levels during treatment with antihypertensive drugs. Acta Med Scand Suppl. 1979;628:69\u201371.","journal-title":"Acta Med Scand Suppl"},{"key":"368_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","volume":"29","author":"M Kanbay","year":"2016","unstructured":"Kanbay M, et al. Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med. 2016;29:3\u20138.","journal-title":"Eur J Intern Med"},{"key":"368_CR42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/HYPERTENSIONAHA.116.07056","volume":"67","author":"C Bavishi","year":"2016","unstructured":"Bavishi C, Messerli FH, Rimoldi SF. Serum uric acid in primary hypertension. Hypertension. 2016;67:845\u20137.","journal-title":"Hypertension"},{"key":"368_CR43","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.115.06852","volume":"67","author":"F Viazzi","year":"2016","unstructured":"Viazzi F, et al. Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk. Hypertens (Dallas, Tex 1979). 2016;67:934\u201340.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"368_CR44","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.114.03953","volume":"64","author":"CJ Beattie","year":"2016","unstructured":"Beattie CJ, et al. Allopurinol initiation and change in blood pressure in older adults with hypertension. Hypertens (Dallas, Tex 1979). 2016;64:1102\u20137.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"368_CR45","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","volume":"319","author":"S Hollis","year":"1999","unstructured":"Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319:670\u20134.","journal-title":"BMJ"},{"key":"368_CR46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nature08984","volume":"464","author":"JW Vaupel","year":"2010","unstructured":"Vaupel JW. Biodemography of human ageing. Nature. 2010;464:536\u201342.","journal-title":"Nature"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0368-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:10:14Z","timestamp":1718824214000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0368-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0368-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]},"article-number":"188"}}